Study S001432

A Single-center, Double-blinded, Randomized, Placebo-controlled Trial to Evaluate the Effectiveness and Safety of Low-frequency Injection of HRS9531 in Control of Weight Regain in Obese Subjects With and Without Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT06287437
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 72
Start: 2024-01-01
Primary completion: 2025-06-30
Lead sponsor: Shanghai Zhongshan Hospital
Conditions: Obesity
Interventions: DRUG:HRS9531; DRUG:HRS9531 placebo
Results posted: FALSE

Registered primary outcomes

Percent Change in Body Weight from 24 weeks [36 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.